AKT1 and stroke disorder: Studies have also shown that THSWT can reduce cerebral infarct volume and improve neurological function in stroke model rats by modulating the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways [14].